Navigation Links
GMSbiotech and Pure Transplant Solutions Announce Strategic Collaboration
Date:11/18/2013

Inverness, Ill and Oklahoma City, OK (PRWEB) November 18, 2013

GMSbiotech, Inc. (GMS), creator of novel microarray-based diagnostic solutions for personalized medicine and transplantation compatibility and Pure Transplant Solutions, LLC, (PTS) a leader in soluble HLA reagents production and application development, today announced a partnership that will leverage the GMS platform and the PTS soluble HLA technology including its suite of over 200 Class I and Class II alleles, anticipated to grow to 300 alleles over the duration of the project.

"We have invested over $15M in the last 14 years to develop the PTS reagent technology and GMS has invested over $10M in the last 10 years developing their platform," said Thomas Harlan, CEO Pure Transplant Solutions, "Leveraging our combined infrastructures and unique strengths will allow us to develop a novel technology solution while lowering the risk, time and costs normally associated with these types of ventures."

"We are excited about this collaboration and look forward to the development of a prototype which we hope to distribute by Q3 2014 to select ASHI certified labs for beta testing," said Dr. Krishna Jayaraman, President & CEO of GMSbiotech.

About GMSbiotech, Inc.

GMSbiotech (GMS) is a privately held company focusing on its patented microarray platform to develop accurate and affordable genetic and serology tests. With the company’s disruptive technology in Raw Sample Genotyping (RSG) combined with its microarray platform, complex genetic testing experienced by labs across the field has been substantially simplified into a routine, everyday low-cost component of clinical diagnostics and public health screening. The company is commercializing its technologies with an initial focus on transplantation diagnostics. For additional information on the company please visit http://www.gmsbiotech.com.

About Pure Transplant Solutions, LLC

Pure Transplant Solutions, L.L.C. ("PTS") is a subsidiary of Pure Protein L.L.C, a company that has developed and patented several soluble HLA protein technology methods and immunology tools for therapeutic and diagnostic applications in solid organ and stem cell transplantation, cross-reactive antibody screening, and major autoimmune diseases. Pure Protein was formed in 1999 to commercialize research developed by Dr. William Hildebrand at the University of Oklahoma Health Sciences Center. Pure Transplant Solutions was formed in 2003 to use HLA protein to develop diagnostics, devices, and therapeutics to help eliminate transplant rejection. To learn more visit http://www.pureproteinllc.com.

Pure Protein and its subsidiaries are funded and managed by innovation solutions company Emergent Technologies, Inc. For more information visit http://www.emergenttechnolgogies.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11341302.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Case Report Published in the Journal Perfusion on 14-Year-Old Pediatric Patient Bridged to Transplant with SynCardia Total Artificial Heart
2. Adaptive Biotechnologies Receives $2.53 million Phase II SBIR to Develop Test to Identify Cancer Patients at Risk of Death by Infection after Cord Blood Transplants
3. UK’s 1st SynCardia Total Artificial Heart Patient Bridged to Transplant at Papworth Hospital
4. OrganJet customer receives kidney transplant years faster due to smart multiple listing
5. Pure Transplant Solutions Launches Crowdfunding Campaign for Its Novel Technology Poised to Change the Future of Organ Transplantation
6. SynCardia Total Artificial Heart Bridges Mother of Four with Congenital Heart Defect & Biventricular Heart Failure to Transplant
7. Universal Stem Cell Product Could Overcome Key Challenges in Donor Organ Transplants
8. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
9. Researchers identify signals that direct the immune system to reject a transplanted organ
10. Stem cell transplant restores memory, learning in mice
11. Stem cells produce compact, regenerated bone in mandible transplants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building and cooking ... initiative announced today. The bold new look is part of a transformation to ... into a significant growth period. , It will also expand its service offering from ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
(Date:10/9/2017)... ... 2017 , ... At its national board meeting in North Carolina, ARCS® ... Departments of Physics and Astronomy, has been selected for membership in ARCS Alumni ... the 2015 Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion ...
Breaking Biology Technology:
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
Breaking Biology News(10 mins):